U.S. Paper and Forestry Products Stock News

Hesai Group (NasdaqGS:HSAI) has just posted its FY 2025 third quarter numbers, with revenue of C¥795.4 million and basic EPS of C¥1.88 setting the tone for the latest update. The company has seen quarterly revenue move from C¥458.9 million in Q2 2024 to C¥719.8 million in Q4 2024 and then to C¥795.4 million in Q3 2025. Basic EPS has shifted from a loss of C¥0.56 per share in Q2 2024 to C¥1.13 in Q4 2024 and C¥1.88 in Q3 2025, pointing to a business where margins are increasingly in focus for...

Last week's earnings announcement from Turtle Beach Corporation ( NASDAQ:TBCH ) was disappointing to investors, with a...

Over the last 7 days, the United States market has dropped 2.3%, yet it remains up by 13% over the past year with earnings forecasted to grow by 16% annually. In this context of fluctuating performance, identifying small-cap stocks with potential insider buying can be an intriguing strategy for investors seeking opportunities that may not be immediately apparent in larger market trends.

Over the last 7 days, the United States market has experienced a 2.3% drop, yet it remains up by 13% over the past year with earnings projected to grow by 16% annually. In this context, identifying stocks that are trading below their intrinsic value can present opportunities for investors seeking to capitalize on potential long-term gains amidst fluctuating market conditions.

The recent 13% drop in Indaptus Therapeutics, Inc.'s ( NASDAQ:INDP ) stock could come as a blow to insiders who...

Over the last 7 days, the U.S. market has dropped by 2.3%, though it has shown a robust increase of 13% over the past year, with earnings projected to grow by 16% annually in the coming years. In such fluctuating conditions, identifying stocks with strong fundamentals and solid balance sheets can be crucial for investors seeking growth opportunities at lower price points. Penny stocks, often representing smaller or newer companies, continue to present underappreciated potential for growth and...

Over the last 7 days, the United States market has experienced a 2.3% drop, yet it has shown resilience with a 13% rise over the past year and earnings are expected to grow by 16% annually. In such dynamic conditions, dividend stocks can offer investors stability and income potential, making them an attractive option for those seeking steady returns amidst market fluctuations.

Insiders who bought US$1.73m worth of Cartesian Therapeutics, Inc.'s ( NASDAQ:RNAC ) stock at an average buy price of...

We feel now is a pretty good time to analyse CollPlant Biotechnologies Ltd.'s ( NASDAQ:CLGN ) business as it appears...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

We wouldn't blame Viemed Healthcare, Inc. ( NASDAQ:VMD ) shareholders if they were a little worried about the fact that...

Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...

The Morning Bull - US Market Morning Update Wednesday, Mar, 25 2026 US stock futures are pointing higher this morning, with key contracts on the S&P 500 and Nasdaq up around 1%, as investors weigh easing tensions in the Middle East against stubbornly high borrowing costs. The US 10 year Treasury yield is sitting above 4.4%, an eight month high, which means mortgages, car loans and business financing remain expensive. At the same time, fresh US business surveys show manufacturing at 52.4 and...

Some Powell Industries, Inc. ( NASDAQ:POWL ) shareholders may be a little concerned to see that insider Thomas Powell...

Fennec Pharmaceuticals (FENC) just posted its FY 2025 third quarter numbers, with revenue of US$12.5 million and a basic EPS loss of US$0.02, while net income excluding extra items came in at a loss of US$0.6 million. Over recent quarters the company has seen revenue move from US$7.3 million in Q2 FY 2024 to US$9.7 million in Q2 FY 2025 and then to US$12.5 million in Q3 FY 2025. Over the same period, basic EPS shifted from a loss of US$0.20 in Q2 FY 2024 to a loss of US$0.11 in Q2 FY 2025 and...

The US government has launched a multi trillion dollar consortium to support critical semiconductor and advanced manufacturing supply chains as part of an expanded Pax Silica program. The initiative aims to channel substantial funding into domestic fabrication, tooling, industrial lasers and related infrastructure over the medium term. IPG Photonics, listed as NasdaqGS:IPGP, sits within the industrial laser segment that is closely tied to these manufacturing and semiconductor build...

If you are wondering whether National Beverage at around US$33.71 is a bargain or a value trap, this breakdown will help you connect the share price to what the business may be worth. The stock is up 6.5% year to date, although it has seen a 2.6% slip over the last week and an 8.9% decline over the last month. The 1 year return of 16.1% and 3 year return of 31.2% highlight how sentiment has shifted over time. Recent coverage has focused on National Beverage's position in the soft drinks...

Marathon Petroleum (NYSE:MPC) has scheduled a shareholder vote on a proposed amendment to its Certificate of Incorporation at the 2026 Annual Meeting. The proposal focuses on corporate governance terms that could influence shareholder rights and future decision making at the company. Investors will have the opportunity to review and vote on the amendment as part of the formal meeting agenda. Marathon Petroleum operates as a large US refiner and fuel marketer, so changes to its governance...

Veracyte, NasdaqGM:VCYT, has appointed Kevin Haas, Ph.D., as Chief Development and Technology Officer in a newly created executive role. Dr. Haas will oversee assay development, software, AI, and next generation informatics across Veracyte's product pipeline. The move reflects Veracyte's focus on whole genome MRD and multi omics applications across its global portfolio. Veracyte's share price stands at $32.94, with a return of 60.1% over the past 3 years and a 2.2% decline over the past...

Janus Living (NYSE:JAN) has arranged $600 million in new unsecured credit facilities. The package includes a $500 million unsecured revolving credit facility and a $100 million unsecured delayed draw term loan facility. The new funding is intended to increase liquidity and support future expansion plans. For investors watching NYSE:JAN, the new credit facilities arrive with the stock at $23.75 and a year-to-date return of 0.6%. The move reshapes Janus Living's funding options as a REIT and...

Perma-Fix Environmental Services (PESI) FY 2025 earnings snapshot Perma-Fix Environmental Services (PESI) reported third quarter FY 2025 revenue of US$17.5 million with a basic EPS loss of US$0.10, while trailing twelve month EPS stood at a loss of US$0.64 on revenue of US$60.7 million. This highlights that the business remains in loss making territory. Over recent quarters, revenue has ranged from US$13.9 million to US$17.5 million, while quarterly EPS losses have moved between US$0.09 and...

If you are wondering whether AvePoint's current share price lines up with its underlying worth, this breakdown will help you make sense of what the market is implying. The stock recently closed at US$9.61, with returns of 8.4% decline over 7 days, 8.5% decline over 30 days, 27.3% decline year to date, 36.9% decline over 1 year, 146.4% gain over 3 years, and 13.3% decline over 5 years, so the recent share price path has been mixed across different time frames. Recent news coverage has focused...

Investors may be wondering if Webster Financial at around US$68.67 is offering reasonable value today, or if the recent run has already priced in the upside. The stock is up 34.0% over the past year and 93.1% over three years, with a 7.6% gain year to date, even though it has seen a 6.0% decline over the last month and a small 0.3% move over the past week. Recent attention on banks listed on the New York Stock Exchange has put valuation and balance sheet quality back in focus, and Webster...

Recent Results Set the Stage for Battalion Oil’s Next Chapter Battalion Oil (BATL) just posted its latest FY 2025 numbers with Q3 revenue of US$43.5 million and a basic EPS loss of US$0.91, alongside trailing twelve month revenue of US$183.4 million and a basic EPS loss of US$3.35. Over the past few quarters, total revenue has moved between US$42.8 million and US$49.7 million while quarterly basic EPS has ranged from a loss of US$1.88 to a profit of US$0.34. This gives investors a mixed read...